- Home
- GSHD vs WVE Comparison
GSHD vs WVE Comparison
Compare GSHD & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSHD
- WVE
- Stock Information
- Founded
- GSHD 2003
- WVE 2012
- Country
- GSHD United States
- WVE Singapore
- Employees
- GSHD N/A
- WVE N/A
- Industry
- GSHD Specialty Insurers
- WVE Biotechnology: Pharmaceutical Preparations
- Sector
- GSHD Finance
- WVE Health Care
- Exchange
- GSHD Nasdaq
- WVE Nasdaq
- Market Cap
- GSHD 2.6B
- WVE 2.1B
- IPO Year
- GSHD 2018
- WVE 2015
- Fundamental
- Price
- GSHD $104.91
- WVE $13.24
- Analyst Decision
- GSHD Buy
- WVE Strong Buy
- Analyst Count
- GSHD 12
- WVE 10
- Target Price
- GSHD $95.33
- WVE $21.60
- AVG Volume (30 Days)
- GSHD 225.4K
- WVE 1.0M
- Earning Date
- GSHD 02-19-2025
- WVE 11-12-2024
- Dividend Yield
- GSHD N/A
- WVE N/A
- EPS Growth
- GSHD 46.50
- WVE N/A
- EPS
- GSHD 0.68
- WVE N/A
- Revenue
- GSHD $282,564,000.00
- WVE $53,610,000.00
- Revenue This Year
- GSHD $17.43
- WVE N/A
- Revenue Next Year
- GSHD $25.28
- WVE $48.58
- P/E Ratio
- GSHD $158.66
- WVE N/A
- Revenue Growth
- GSHD 11.18
- WVE N/A
- 52 Week Low
- GSHD $50.47
- WVE $3.50
- 52 Week High
- GSHD $130.39
- WVE $16.74
- Technical
- Relative Strength Index (RSI)
- GSHD 39.75
- WVE 43.51
- Support Level
- GSHD $101.59
- WVE $12.09
- Resistance Level
- GSHD $106.71
- WVE $13.85
- Average True Range (ATR)
- GSHD 3.51
- WVE 0.87
- MACD
- GSHD -0.84
- WVE -0.17
- Stochastic Oscillator
- GSHD 35.04
- WVE 22.06
About GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.